Evaluation of molecular profiles allows a more precise risk classification of PCa [2], and within this classification alteration in ETS-related gene (ERG) and phosphatase tensin homologue (PTEN) are among the most common genomic alterations to occur in PCa [3,4]. The gene discussed is ERG; the disease is posterior cortical atrophy.